Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Molecular Biology›Cell Cycle
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Cell Cycle

Molecular Biology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

The complex series of phenomena, occurring between the end of one cell division and the end of the next, by which cellular material is duplicated and then divided between two daughter cells.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (492 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The complex series of phenomena, occurring between the end of one cell division and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes interphase, which includes G0 phase; G1 phase; S phase; and G2 phase, and cell division phase.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Cell Cycles; Cycle, Cell; Cycles, Cell; Cell Division Cycle; Cell Division Cycles; Cycle, Cell Division; Cycles, Cell Division; Division Cycle, Cell.

Where it fits in the MeSH classification

Broader topics
Cell Physiological Phenomena
Narrower topics
Cell Cycle Checkpoints; Cell Division; Interphase
See also
Cell Cycle Proteins; Genes, cdc

Related concepts

  • Cell Division
  • Interphase
  • Phase
  • Cell Division

Research landscape

PubMed indexes 359,497 records tagged with the MeSH heading “Cell Cycle” (counts retrieved 2026-10-29). 25,312 of them (7.0%) were published from 2020 onward, and the busiest period so far is through 1999 with 165,592 records.

Reviews account for 32,626 records (9.1%) and meta-analyses for 133. Randomized controlled trials number 561 (0.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 165,592 records; 2000-2009: 96,310 records; 2010-2019: 72,283 records; 2020 onward: 25,312 records165,592through 199996,3102000-200972,2832010-201925,3122020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999165,592
2000-200996,310
2010-201972,283
2020 onward25,312
Share of records by publication typeReviews: 9.1 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.2 percentReviews9.1% (32,626)Meta-analyses0.0% (133)Randomized controlled trials0.2% (561)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 359,497 PubMed records
TypeRecordsShare
Reviews32,6269.1%
Meta-analyses1330.0%
Randomized controlled trials5610.2%

Method: PubMed query "Cell Cycle"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in molecular biology

Molecular biology establishes mechanisms through controlled experiments, often in simplified systems such as purified proteins, cultured cells or model organisms. Such work can show what is possible in a defined system, but whether a pathway matters in a whole organism or in human disease needs further evidence. Check the experimental system, whether findings were reproduced by independent groups, and whether the authors tested the mechanism directly or inferred it from correlation.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
The penicillin-binding protein PBP1b fortifies the Escherichia coli division site against osmotic rupture
Navarro PP, Vettiger A, Hajdu R, Ananda VY, López-Tavares A, Schmid EW, et al.
2026Research article
Design not recorded in structured metadata
8cc by
PMID 42399561 · DOI · PMC13423804
Defective transcription of AAGAG satellite DNA causes sex-ratio meiotic drive in Drosophila
Kumon T, Nakamizo-Dojo M, Raz AA, Lannes R, Fingerhut JM, Yamashita YM
2026Research article
Design not recorded in structured metadata
4cc by
PMID 42034642 · DOI · PMC13320161
ESCRT-III assembles around mis-segregated DNA to protect genome stability
Glover J, Talledge N, McCullough J, Alian A, Sadler JBA, Kamboj S, et al.
2026Research article
Design not recorded in structured metadata
3cc by
PMID 42458110 · DOI · PMC13468122

The penicillin-binding protein PBP1b fortifies the Escherichia coli division site against osmotic rupture [1]

Research article Navarro PP, Vettiger A, Hajdu R, Ananda VY, López-Tavares A, Schmid EW, et al. · · 2026 · cited 8 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The divisome apparatus synthesizes septal peptidoglycan (PG) during bacterial division.
Closing excerpt
The conservation of aPBPs with extended cytoplasmic N termini suggests that other Gram-negative bacteria may use similar mechanisms for division site reinforcement.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (155 words)

The divisome apparatus synthesizes septal peptidoglycan (PG) during bacterial division. In Escherichia coli, the class A penicillin-binding protein (aPBP) called PBP1b has been implicated in division, but its role in the process has remained unclear. Here we show using in situ cryo-electron tomography, genetics and other imaging methods that PBP1b is required to produce a wedge-like density of PG at the division site and that loss of this structure weakens the division site, making it hypersusceptible to osmotic lysis. Surprisingly, the activator LpoB needed for general PBP1b function was not required for its role in division. Of the two PBP1b isoforms produced in cells, we show that the one with an extended cytoplasmic N terminus localizes to and functions at the division site, probably via recruitment by the FtsA component of the divisome. The conservation of aPBPs with extended cytoplasmic N termini suggests that other Gram-negative bacteria may use similar mechanisms for division site reinforcement.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42399561 · DOI · PMC13423804

Defective transcription of AAGAG satellite DNA causes sex-ratio meiotic drive in Drosophila [2]

Research article Kumon T, Nakamizo-Dojo M, Raz AA, Lannes R, Fingerhut JM, Yamashita YM · · 2026 · cited 4 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Male germ cells have complex transcriptomes, with a large fraction of the genome being transcribed.
Closing excerpt
We further propose that differential composition and amount of satellite DNA on chromosomes may underlie naturally occurring male meiotic drive.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (181 words)

Male germ cells have complex transcriptomes, with a large fraction of the genome being transcribed. This includes protein-coding genes (often not translated), non-coding DNA, and repetitive DNA, such as transposons and satellite DNA, which are normally silenced as heterochromatin. The significance of such widespread transcription remains unknown. Here, we show that a heterochromatin protein, HP2, is required for the transcription of AAGAG satellite DNA in Drosophila spermatocytes. HP2 depletion leads to abnormal retention of heterochromatin histone marks (H3K9me3) and spermatid death during sperm DNA packaging, leading to a model that transcription of AAGAG satellite DNA facilitates the remodeling of its heterochromatic nature in preparation for sperm DNA packaging. Strikingly, the severity of the spermatid death correlates with the amount of AAGAG satellite DNA carried by the spermatids, leading to preferential death of Y-chromosome-containing spermatids over X-containing spermatids, and hence sex-ratio meiotic drive phenotype. We propose that widespread spermatocyte transcription may reflect the process of chromatin remodeling to allow sperm DNA packaging. We further propose that differential composition and amount of satellite DNA on chromosomes may underlie naturally occurring male meiotic drive.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42034642 · DOI · PMC13320161

ESCRT-III assembles around mis-segregated DNA to protect genome stability [3]

Research article Glover J, Talledge N, McCullough J, Alian A, Sadler JBA, Kamboj S, et al. · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Chromosome mis-segregation events that remain unresolved during cytokinesis threaten genome stability.
Closing excerpt
Lastly, cells expressing a DNA-binding mutant of CHMP1B exhibit cytokinesis failure and binucleation when ultrafine DNA bridges persist, revealing a mechanism of safeguarding genome stability.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (156 words)

Chromosome mis-segregation events that remain unresolved during cytokinesis threaten genome stability. Persistent ultrafine DNA bridges engage the Aurora B-dependent abscission checkpoint (termed NoCut), which delays abscission by phosphorylating components of the ESCRT complex. Here we show that NoCut surveillance repurposes human ESCRT-III, the membrane-remodeling complex that seals the reforming nuclear envelope in anaphase. In response to persistent ultrafine DNA bridges, ESCRT-III transfers from the reforming nuclear envelope to the mis-segregated DNA bridge and ESCRT-III complexes protect the DNA from damage, as evidenced by increased DNA damage upon CHMP1B depletion. Complementary in vitro assembly reactions show that the human ESCRT-III proteins CHMP1B and IST1 can copolymerize into double-stranded filaments that encase double-stranded DNA and nucleosomes and prevent nuclease digestion and cGAS recognition, demonstrating that ESCRT-III complexes can directly bind and protect DNA. Lastly, cells expressing a DNA-binding mutant of CHMP1B exhibit cytokinesis failure and binucleation when ultrafine DNA bridges persist, revealing a mechanism of safeguarding genome stability.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42458110 · DOI · PMC13468122

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis [4]
    Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, et al. · JAMA Oncol · 2018 · cited 869 times (Europe PMC)
  • Research article Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis [5]
    D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Paré G · Circ Cardiovasc Genet · 2015 · cited 279 times (Europe PMC)
  • Research article Principles and dynamics of spindle assembly checkpoint signalling [6]
    McAinsh AD, Kops GJPL · Nat Rev Mol Cell Biol · 2023 · cited 276 times (Europe PMC)
  • Research article Cyclin-dependent protein kinases and cell cycle regulation in biology and disease [7]
    Pellarin I, Dall'Acqua A, Favero A, Segatto I, Rossi V, Crestan N, et al. · Signal Transduct Target Ther · 2025 · cited 256 times (Europe PMC)
  • Research article Telomere Length and All-Cause Mortality: A Meta-analysis [8]
    Wang Q, Zhan Y, Pedersen NL, Fang F, Hägg S · Ageing Res Rev · 2018 · cited 254 times (Europe PMC)
  • Research article Meiosis: Dances Between Homologs [9]
    Zickler D, Kleckner N · Annu Rev Genet · 2023 · cited 183 times (Europe PMC)

References

  1. Navarro PP, Vettiger A, Hajdu R, Ananda VY, López-Tavares A, Schmid EW, et al.. The penicillin-binding protein PBP1b fortifies the Escherichia coli division site against osmotic rupture. . 2026. PMID 42399561 · DOI · PMC13423804
  2. Kumon T, Nakamizo-Dojo M, Raz AA, Lannes R, Fingerhut JM, Yamashita YM. Defective transcription of AAGAG satellite DNA causes sex-ratio meiotic drive in Drosophila. . 2026. PMID 42034642 · DOI · PMC13320161
  3. Glover J, Talledge N, McCullough J, Alian A, Sadler JBA, Kamboj S, et al.. ESCRT-III assembles around mis-segregated DNA to protect genome stability. . 2026. PMID 42458110 · DOI · PMC13468122
  4. Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, et al.. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018. PMID 28973656 · DOI · PMC5838579
  5. D'Mello MJ, Ross SA, Briel M, Anand SS, Gerstein H, Paré G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis. Circ Cardiovasc Genet. 2015. PMID 25406241 · DOI
  6. McAinsh AD, Kops GJPL. Principles and dynamics of spindle assembly checkpoint signalling. Nat Rev Mol Cell Biol. 2023. PMID 36964313 · DOI
  7. Pellarin I, Dall'Acqua A, Favero A, Segatto I, Rossi V, Crestan N, et al.. Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther. 2025. PMID 39800748 · DOI · PMC11734941
  8. Wang Q, Zhan Y, Pedersen NL, Fang F, Hägg S. Telomere Length and All-Cause Mortality: A Meta-analysis. Ageing Res Rev. 2018. PMID 30254001 · DOI
  9. Zickler D, Kleckner N. Meiosis: Dances Between Homologs. Annu Rev Genet. 2023. PMID 37788458 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • InterphaseMolecular Biology
  • S PhaseMolecular Biology
  • G2 PhaseMolecular Biology
  • Cell DivisionMolecular Biology
  • G1 PhaseMolecular Biology
  • Cell DeathMolecular Biology

All 100 articles in Molecular Biology →

At a glance

359,497
PubMed records on this heading
7%
published since 2020
32,626
review articles
561
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • InterphaseMolecular Biology
  • S PhaseMolecular Biology
  • G2 PhaseMolecular Biology
  • Cell DivisionMolecular Biology
  • G1 PhaseMolecular Biology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support